HAEMONETICS ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE SOLUTION (CP2D)  - citric acid monohydrate, trisodium citrate dihydrate, sodium phosphate, monobasic, monohydrate and anhydrous dextrose solution 
Haemonetics Corporation

----------

HAEMONETICS Citrate Phosphate Double Dextrose Solution (CP2D) 250 mL

For use as an anticoagulant solution with Haemonetics MCSR + Red Cell Collection Disposables

DIRECTIONS FOR USE

1. Verify that the appropriate list number of the solution has been selected.

2. Remove bag of LN455A CP2D from over-wrap.
Notes: The over-wrap serves as a moisture barrier and upon removing the solution bag small droplets of condensation may be present. This is considered normal.  The CP2D solution should be used within 8 hours of removing the over-wrap.

3. Inspect the LN455A CP2D bag:
  • Ensure that the CP2D has not expired.
  • Ensure that the luer cap is attached.
  • Ensure that the breakable seal is fully attached.
  • Ensure that the bag is not leaking.
  • Ensure that the CP2D fluid is clear.
Note: Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the quality or safety. The opacity will diminish gradually.

4. Using aseptic technique, remove luer cap from luer connector. 

5. Using aseptic technique, luer attach the CP2D to the anticoagulant line of the apheresis disposable. 

6. Open the in-line breakable seal.
  • Hold the in-line breakable seal.
  • Open the seal by bending the tubing at the seal in a forward and backward motion. 

7. Hang the CP2D with ports down on the left IV pole. 

8. The Haemonetics LN455A CP2D is now ready to prime the disposable.

Note: The collection procedure must be initiated within 4 hours of attaching the solutions to the disposable.

RECOMMENDED STORAGE:

Room temperature (25 degree C/77 degree F). Avoid excessive heat. Protect from freezing.

Rx only. 

Note: No latex is contained in the solution or storage bag components.

(CP2D)

Intended for use only with automated red cell apheresis devices. See Operator's Manual for additional Information and complete usage instructions. 

Each 100 mL contains:

Citric Acid (Monohydrate), USP  0.327 g 
Sodium Citrate (Dihydrate), USP  2.630 g 
Monobasic Sodium Phosphate (Monohydrate), USP  0.222 g 
Dextrose (Anhydrous), USP  4.640 g

CAUTION:

Not for direct Intravenous infusion. The pouch is a moisture barrier. Do not use unless solution is clear and no leaks detected. Single use container. Discard unused portion.

STERILE,

nonpryogenic fluid path. Rx only.

L065, Rev. D-10

Product code 455A  Haemonatics Corporation  Braintree, MA 02184 USA  Lot No.    Exp. Date

HAEMONETICS Citrate Phosphate Double Dextrose Solution (CP2D) 250 mL  For use as an anticoagulant solution with Haemonetics MCSR + Red Cell Collection Disposables  LIST NUMBER 455A

HAEMONETICS Citrate Phosphate Double Dextrose Solution (CP2D) 250 mL  Haemonatics Corporation  Braintree, MA 02184 USA

Product Label - Directions

Directions

Product Label - Package

Label

HAEMONETICS ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE SOLUTION (CP2D)  
citric acid monohydrate, trisodium citrate dihydrate, sodium phosphate, monobasic, monohydrate, anhydrous dextrose solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUG LABELItem Code (Source)NDC:57826-455
Route of AdministrationEXTRACORPOREALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CITRIC ACID MONOHYDRATE (ANHYDROUS CITRIC ACID) ANHYDROUS CITRIC ACID32.7 mg  in 1 mL
TRISODIUM CITRATE DIHYDRATE (ANHYDROUS CITRIC ACID) ANHYDROUS CITRIC ACID263 mg  in 1 mL
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (PHOSPHATE ION) SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE22.2 mg  in 1 mL
ANHYDROUS DEXTROSE (ANHYDROUS DEXTROSE) ANHYDROUS DEXTROSE464 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER 
Packaging
#Item CodePackage Description
1NDC:57826-455-02250 mL in 1 BAG
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA00012701/10/2013
Labeler - Haemonetics Corporation (942344649)
Establishment
NameAddressID/FEIBusiness Operations
Haemonetics Corporation942344649manufacture(57826-455)

Revised: 01/2013
 
Haemonetics Corporation